Adalimumab effect on pain in hidradenitis suppurativa patients: systematic review and meta-analysis
Introduction: Pain is experienced by most patients with hidradenitis suppurativa (HS) and has a severe impact on their quality of life. Its management still presents a challenge. Adalimumab, a TNF-a antagonist, has shown promising results in HS-related pain reduction. Objectives: To aggregate and...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2022-05-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | https://dpcj.org/index.php/dpc/article/view/1996 |